SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is experiencing high volatility as investors weigh stronger-than-expected revenue guidance against the company's decision to launch a 75 million share offering. Community discussion is sharply divided between long-term supporters viewing the capital raise as a necessary step to secure government manufacturing loans and frustrated traders criticizing management for diluting shares and stalling positive price momentum.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is gaining momentum as investors pivot toward the company following news of its strategic shift to close internal discovery facilities, fueling community speculation about a potential buyout or M&A activity. Market participants are actively discussing the stock's improved capital efficiency and pipeline potential while monitoring heavy volume and unusual options activity for signs of a breakout.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining significant momentum as investors anticipate key clinical milestones and weigh the potential for a strategic partnership or buyout within the high-growth obesity drug sector. The community is intensely focused on the upcoming maintenance study results, which many view as a critical catalyst for the stock's valuation, while simultaneously debating the aggressive short interest and the company's long-term independence.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is surging as investors closely monitor its role in AI infrastructure, specifically highlighting its CXL memory technology and status as an NVIDIA AI Factory Specialized Partner. The community is actively debating the stock's long-term valuation potential while navigating significant volatility ahead of the upcoming earnings report.

American Bitcoin Corp. engages in the management of a bitcoin accumulation platform. It offers exposure to bitcoin through an industry-first business model that integrates scaled self-mining operations with disciplined accumulation strategies. The company was founded by Eric Trump and Donald John Trump Jr. on October 3, 2018 and is headquartered in Miami, FL.

American Bitcoin Corp. - Ordinary Shares - Class A

American Bitcoin Corp.

American Bitcoin Corp. (ABTC) is facing significant investor backlash as shareholders weigh the impact of an approved reverse stock split against ongoing concerns over extreme dilution and the company's association with the Trump family. The community is sharply divided, with some investors aggressively accumulating shares in hopes of a technical rebound or sector-wide crypto rally, while others are calling for regulatory investigations and labeling the stock a failed pump-and-dump scheme.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors debate whether the recent sector-wide semiconductor sell-off, sparked by external market volatility, represents an overreaction or a fundamental shift for the company. While the community remains deeply divided, with some traders citing long-term geopolitical and foundry growth potential as a reason to hold, others are closely monitoring technical support levels amid concerns over high valuations and broader market risk-off sentiment.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending as renewed military strikes in the Strait of Hormuz disrupt global energy shipping, forcing investors to weigh heightened geopolitical risk against attempts by officials to manage supply concerns. The community is actively debating the durability of the current maritime truce and whether ongoing infrastructure attacks will cause a sustained supply squeeze despite recent downward price pressure.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a sharp surge in price driven by a strategic 380-megawatt clean power agreement for data centers and the securing of a non-dilutive $49 million financing package from the U.S. Export-Import Bank. The community is actively discussing the stock's transition into momentum mode, with long-term shareholders debating whether this growth signals a sustained reversal or a familiar cycle of dilution and volatility.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is attracting significant attention as investors react to the launch of a majority-owned joint venture with Toyota, aimed at scaling commercial eVTOL production. While bulls emphasize this manufacturing alliance and progress in FAA certification as key long-term catalysts, the stock continues to experience high volatility and intense short-interest, sparking active community debates between those anticipating a major breakout and those concerned about ongoing cash burn and dilution.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending following the FDAs accelerated approval of its lead drug, TRUTAKNA (atacicept), for the treatment of adults with primary IgA nephropathy. While the community is debating the muted post-approval price action, investors remain focused on the drug's commercial potential as the first dual BAFF/APRIL inhibitor in a competitive market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no...

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm PR Newswire NEW YORK, July 2, 2026 NEW YORK, July 2, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap

16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap PR Newswire TORONTO, ON, June 16, 2026 Issued on behalf of Ventripoint Diagnostics Ltd.As the number of...

iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains

iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains...

Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's  What You Should Know

The consensus price target hints at a 57.2% upside potential for IRHYTHM HLDGS (IRTC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Why iRhythm Holdings, Inc. (IRTC) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Comerica Bank Sells 13,381 Shares of iRhythm Technologies $IRTC

Comerica Bank cut its stake in shares of iRhythm Technologies (NASDAQ:IRTC - Free Report) by 47.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and...

Citigroup Issues Positive Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price

Citigroup increased their price objective on shares of iRhythm Technologies from $155.00 to $157.00 and gave the company a "buy" rating in a report on Monday...

IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised

iRhythm narrows Q1 losses, lifts 2026 outlook and posts 25.7% revenue growth as strong demand and margin gains drive momentum.

iRhythm Technologies (NASDAQ:IRTC) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of iRhythm Technologies (NASDAQ:IRTC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fifteen ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating...

iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

iRhythm Holdings Inc.

Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

IRTCiRhythm Technologies Inc

Fundamentals

Latest IRTC News